Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
498
datasets available to search
ShareScore release 0.7.1
Dataset results
498 results for “liver fibrosis”
Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver D
ClinicalTrials.gov study NCT02658786. IPD Sharing: NO. Countries: 1. Publications: 0.
Prospective Studies on Immunopathogenesis of Liver Fibrosis
ClinicalTrials.gov study NCT04943978. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C)
ClinicalTrials.gov study NCT02439567. IPD Sharing: Not stated. Countries: 1. Publications: 0.
18F-FAPI PET in the Diagnosis of Liver Fibrosis
ClinicalTrials.gov study NCT05262647. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT04232293. IPD Sharing: NO. Countries: 1. Publications: 0.
Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis
ClinicalTrials.gov study NCT03842748. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM
ClinicalTrials.gov study NCT06762223. IPD Sharing: NO. Countries: 1. Publications: 0.
Liver and Spleen Stiffness Measured by 2D-SWE for Diagnosis of Liver Fibrosis in Patients With cACLD
ClinicalTrials.gov study NCT06147934. IPD Sharing: NO. Countries: 1. Publications: 0.
Development of Novel MRI Methods for Detecting, Discriminating, and Measuring Liver Fibrosis and Congestion in Fontan Patients
ClinicalTrials.gov study NCT03539757. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Ass
ClinicalTrials.gov study NCT06797596. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Liver Disease, Myocardial Fibrosis and Collaterals in the Adult Fontan Patient a Metabolomics and Proteomics Approach
ClinicalTrials.gov study NCT04764305. IPD Sharing: NO. Countries: 1. Publications: 0.
Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver Fibrosis
ClinicalTrials.gov study NCT03919565. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Feasibility of Human Umbilical Cord Mesenchymal Stem Cell-Derived Secretome in the Treatment of Liver Cirrhosis: a Comprehensive Evaluation of Fibrosis Reduction, Immunomodulation, and Hepa
ClinicalTrials.gov study NCT06629909. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluation of Liver Fibrosis Staging With Acoustic Radiation Force Impulse Elastography
ClinicalTrials.gov study NCT01283230. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease
ClinicalTrials.gov study NCT00004315. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment
ClinicalTrials.gov study NCT05384652. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis
ClinicalTrials.gov study NCT05402371. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets
ClinicalTrials.gov study NCT03979417. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of SGLT-2 Inhibitors in Patients With T2DM and Moderate to Severe Liver Fibrosis
ClinicalTrials.gov study NCT05943899. IPD Sharing: NO. Countries: 1. Publications: 0.
Non-invasive Assessment of Liver Fibrosis in a French Cohort of Pediatric Patients With Type III Glycogen Storage Disease: Current State and Perspectives
ClinicalTrials.gov study NCT07303140. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.